|
|
|
Insider
Information: |
Heerma Peter |
Relationship: |
|
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
99,503 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$680,601 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
99,503 |
|
|
Total
Value |
$680,601 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Travere Therapeutics, Inc |
TVTX |
|
2024-02-01 |
99,503 |
2019-10-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2019-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
35,000 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2020-10-05 |
4 |
AS |
$19.35 |
$42,338 |
D/D |
(2,188) |
42,329 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2020-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
44,000 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2020-10-02 |
4 |
AS |
$18.90 |
$41,353 |
D/D |
(2,188) |
44,517 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2021-02-03 |
4 |
AS |
$28.91 |
$16,276 |
D/D |
(563) |
57,094 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2021-02-02 |
4 |
AS |
$30.75 |
$17,312 |
D/D |
(563) |
57,657 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2021-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
58,220 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2022-01-24 |
4 |
AS |
$24.98 |
$46,838 |
D/D |
(1,875) |
58,582 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2021-02-08 |
4 |
AS |
$31.58 |
$35,528 |
D/D |
(1,125) |
59,344 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2021-10-04 |
4 |
S |
$24.77 |
$75,746 |
D/D |
(3,058) |
60,457 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2021-02-05 |
4 |
AS |
$31.41 |
$35,336 |
D/D |
(1,125) |
60,469 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
61,594 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2021-08-17 |
4 |
S |
$17.12 |
$24,086 |
D/D |
(1,407) |
63,515 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2023-01-24 |
4 |
S |
$21.90 |
$33,952 |
D/D |
(1,550) |
63,598 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2021-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
64,922 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2022-10-04 |
4 |
S |
$25.68 |
$78,119 |
D/D |
(3,042) |
65,148 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2022-01-31 |
4 |
AS |
$27.40 |
$30,825 |
D/D |
(1,125) |
67,297 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,840 |
68,422 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
CHIEF COMMERCIAL OFFICER |
|
2024-01-23 |
4 |
S |
$9.07 |
$14,138 |
D/D |
(1,559) |
78,698 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2023-10-03 |
4 |
S |
$8.25 |
$25,504 |
D/D |
(3,091) |
80,257 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2023-02-01 |
4 |
S |
$21.75 |
$38,697 |
D/D |
(1,779) |
82,069 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Commercial Officer |
|
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,250 |
83,848 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
CHIEF COMMERCIAL OFFICER |
|
2024-02-01 |
4 |
S |
$8.53 |
$35,789 |
D/D |
(4,195) |
99,503 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
CHIEF COMMERCIAL OFFICER |
|
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
103,698 |
0 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|